Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes

[1]  A. Davenport,et al.  Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. , 2020, Kidney international.

[2]  P. Rothwell,et al.  Does Chronic Kidney Disease Predict Stroke Risk Independent of Blood Pressure? , 2019, Stroke.

[3]  B. Zinman,et al.  Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes. , 2019, Journal of the American College of Cardiology.

[4]  Publisher's Note , 2018, Anaesthesia.

[5]  R. Klein,et al.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement , 2017, The Journal of clinical endocrinology and metabolism.

[6]  L. Geiss,et al.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.

[7]  S. Johansson,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[8]  I. D. de Boer,et al.  Diabetic Kidney Disease: A Report From an ADA Consensus Conference , 2014, Diabetes Care.

[9]  Yilong Wang,et al.  Association of Glomerular Filtration Rate With Outcomes of Acute Stroke in Type 2 Diabetic Patients: Results From the China National Stroke Registry , 2013, Diabetes Care.

[10]  T. Craven,et al.  Reversibility of Fenofibrate Therapy–Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants , 2012, Diabetes Care.

[11]  R. Rosenson,et al.  Does microvascular disease predict macrovascular events in type 2 diabetes? , 2011, Atherosclerosis.

[12]  L. Glynn,et al.  Definition of chronic kidney disease and measurement of kidney function in original research papers: a review of the literature. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Shen-Chih Chang,et al.  Impact of Microalbuminuria on Incident Stroke: A Meta-Analysis , 2010, Stroke.

[14]  M. Shlipak,et al.  Albuminuria and the risk of incident stroke and stroke types in older adults , 2010, Neurology.

[15]  Rodica Pop-Busui,et al.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.

[16]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[17]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[18]  R. Kawamori,et al.  Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes. , 2009, Diabetes research and clinical practice.

[19]  H. Yokoyama,et al.  Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16 , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[20]  J. Danziger.  Importance of low-grade albuminuria. , 2008, Mayo Clinic proceedings.

[21]  Xilin Yang,et al.  Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients – the Hong Kong diabetes registry , 2007, Cardiovascular Diabetology.

[22]  E. Air,et al.  Diabetes, the Metabolic Syndrome, and Ischemic Stroke , 2007, Diabetes Care.

[23]  R. Ozaki,et al.  Interactive effect of retinopathy and macroalbuminuria on all‐cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[24]  Ronald Klein,et al.  Diabetic Retinopathy and the Risk of Coronary Heart Disease , 2007, Diabetes Care.

[25]  D. Goff,et al.  Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. , 2007, The American journal of cardiology.

[26]  Seppo Lehto,et al.  Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women , 2007, Diabetes Care.

[27]  G. Bruno,et al.  Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study , 2007, Diabetologia.

[28]  Ann Marie Schmidt,et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. , 2006, Circulation.

[29]  D. Levy,et al.  Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.

[30]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[31]  D. Faraggi,et al.  Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria. , 2004, Journal of the American College of Cardiology.

[32]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[33]  R. Klein,et al.  The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  A. Słowik,et al.  Microalbuminuria in Nondiabetic Patients with Acute Ischemic Stroke: Prevalence, Clinical Correlates, and Prognostic Significance , 2002, Cerebrovascular Diseases.